US 6685949
Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans
expired A61KA61K2039/5555A61K2039/55572
Quick answer
US patent 6685949 (Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis infections in humans) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Feb 03 2004 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 29 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 12
- CPC classes
- A61K, A61K2039/5555, A61K2039/55572, A61K2039/6037, A61K39/1045